Tag Archives: Goldman Sachs

Russian Bank Pioneers Find a New Kick: Marijuana

Russian Bank Pioneers Find a New Kick: Marijuana

Russian Bank Pioneers Find a New Kick: Marijuana

Two banking pioneers during Russia’s chaotic lurch toward capitalism a quarter century ago think they’ve finally found another emerging market that can give them the same buzz.

GWPH Phase 3 Results

GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising $289.8 Million on the NASDAQ Global Market and Full Exercise of Underwriter’s Option to Purchase Additional ADSs

LONDON, July 18, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the closing of the previously announced offering on the NASDAQ Global Market.

GWPH Phase 3 Results

GW Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare Conference and the Jefferies 2016 Healthcare Conference

LONDON, May 31, 2016 /Weed Wire/ — GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) today announced that Justin Gover, GW’s Chief Executive Officer, is scheduled to present at the Goldman Sachs 37th Annual Global Healthcare Conference.


Top